Lpsd/Tlr4
|
Tlr4P712H
|
−7.833 |
C3H/HeJ |
Resistance to LPS (7) |
Albino/Tyr |
TyrC103S
|
−9.738 |
BALB/cJ |
Albinism (13) |
CyfipM1N/Cyfip2
|
Cyfip2S968F
|
−5.251 |
C57BL/6NJ |
Retinal degeneration (17) |
Interstrain gene variants/gene |
|
|
|
|
Rd8/Crb1 |
Crb1R1161G
|
NA: SG: 14% shorter protein |
C57BL/6NJ |
Response to cocaine and methamphetamine (18) |
Adamts12 |
Adamts12C1518F
|
−7.131 |
C57BL/6NJ |
Cancer phenotype (19) |
Ugt genes |
R > S |
−4.545 to −4.791 |
C57BL/6NJ |
Poor detoxification |
Adamts4 |
Adamts4L17F
|
NA: SG: 96% shorter protein |
FVB/NJ |
Resistance to atherosclerosis (22) |
Ccr5 |
Ccr5P185L
|
−9.103 |
FVB/NJ |
Resistance to acetaminophen (23–25) |
Brca1 |
Brca1N623S
|
−3.369 |
CAST/EiJ |
Breast cancer susceptibility |
Brca2 |
Brca2L1495del
|
−12.166 |
CAST/EiJ |
Breast cancer susceptibility |
Nlrp3 |
Nlrp3P214A
|
−7.090 |
CAST/EiJ |
Deficient NLRP3 inflammasome function |
Tnfrsf1b |
Tnfrsf1bP431L
|
−7.325 |
129 strains |
Resistance to TNF-mediated inflammation |
BTBR T+ Itpr3tf/J |
LP/J |
Ripk3 |
Ripk3T166K
|
−5.114 |
BTBR T+ Itpr3tf/J |
Resistance to necroptosis |
DBA/2J |
IL1a |
IL1aY118_T119del
|
−11.218 |
C3H/HeN |
Resistance to IL1α-mediated inflammation |
C3H/HeJ |
Il1r1 |
Il1r1E500G
|
−6.401 |
PWK/PhJ |
Resistance to IL1-mediated inflammation |